The Opioid Epidemic

The opioid epidemic moved in three waves — prescription pills, then heroin, then fentanyl — and has cost hundreds of thousands of lives. The tools that turn the tide already exist: medication, naloxone, and meeting people where they are.

Jessica Miller is the Content Manager of Addiction HelpWritten by
Kent S. Hoffman, D.O. is a founder of Addiction HelpMedically reviewed by Kent S. Hoffman, D.O.
Last updated

Battling addiction & ready for help?

Find Treatment Now

What the Opioid Epidemic Is, in Plain Terms

If the crisis has reached your own family, or your own use feels like it is sliding somewhere you did not choose, here’s the plain truth first. The opioid epidemic is the decades-long surge in addiction and overdose death from opioids in the United States, and it is a treatable medical condition, not a moral failing.

It moved through the country in three waves: first prescription painkillers, then heroin, then illicit fentanyl.

The most important fact comes before any of the numbers. The medications that work are real, recovery happens every day, and the overdose that kills can be reversed if someone acts in time.

An opioid overdose can be reversed if you act fast. Call or text 988 if you or someone you love is in danger.
If you or someone you love is in crisis, call or text 988 now.

What to do:

  • Carry naloxone (Narcan). It reverses an opioid overdose within minutes and cannot be misused to get high — give it and call 911, then start medication for opioid use disorder once the person is stable. Because the street supply is mostly fentanyl, one dose is often not enough, so give another and stay until help arrives[1].
  • Get into treatment. Medications like methadone and buprenorphine (Suboxone) ease withdrawal and cut the risk of overdose death — the easier way out, not white-knuckling it[2].
  • Never use alone. Today’s illicit supply is widely contaminated with fentanyl, so have someone nearby who can give naloxone and call 911.

Find treatment today →

AddictionHelp.com Fast Facts
  • The crisis came in three waves: prescription painkillers, then heroin, then illicit fentanyl, each deadlier than the last.
  • It killed 53,774 Americans in 2024: roughly double the toll of twenty years earlier, with 9.37 million US adults carrying an opioid use disorder.
  • The medications that work cut the risk of dying by about half: methadone or buprenorphine, yet only 25.1% of people with the disorder receive them.

This guide walks through how the epidemic happened, how big it really is, where it stands today, and the solutions saving lives right now. The story is sobering, but it does not end in despair.

The Three Waves that Built the Crisis

The three wavesA shorthand for how the epidemic changed character over time, as the main driver of addiction and death shifted from one kind of opioid to the next.

The epidemic did not arrive all at once. It built in three distinct waves, and understanding them explains why so many families who never expected this found themselves inside it.

Wave Years What drove it
Wave one: prescription pills Late 1990s onward A sharp rise in prescribing of painkillers like OxyContin, fueled by industry research that downplayed the addiction risk
Wave two: heroin Around 2010 People already dependent on pills moved to cheaper, easier-to-find street heroin
Wave three: illicit fentanyl 2013 to today Synthetic fentanyl flooded the supply, far more potent and deadly than anything before it

Wave One Started in the Medicine Cabinet

The first wave began in the late 1990s with prescription painkillers. After 1996, prescribing of drugs like OxyContin expanded sharply, driven in part by manufacturer-funded research that misrepresented how addictive these drugs were.

Doctors prescribed prescription opioids in good faith for back pain, surgery, and injury. Most patients never developed a problem.

But a meaningful minority did. Roughly 8 to 12% of people who misuse opioids go on to develop an opioid use disorder[3]. Across a population filling tens of millions of prescriptions, that share added up to a public-health emergency.

Wave Two Moved People to Heroin

The second wave followed as pills became harder and more expensive to get. Reformulating OxyContin to resist crushing was meant to curb misuse, and it did reduce abuse of that specific pill — but many people simply shifted to other drugs[4].

  • Cheaper street supply. Many already-dependent people moved to heroin, which was easier to find on the street.
  • A clear signal in the data. After abuse-deterrent OxyContin arrived, heroin exposures climbed in national poison reports[5].
  • A well-documented pathway. The road from prescription to needle caught people who had started with nothing more than a legitimate prescription.

Wave Three Is the Fentanyl Era We Live in Now

What contamination means hereThe danger is no longer just the drug a person chooses, but what has been secretly mixed into it — so the same risk now reaches people who never set out to take fentanyl at all.

The third wave is the deadliest, and it is the one the country is living in today. The illicit supply is now dominated by illicitly manufactured fentanyl, a synthetic opioid roughly 50 to 100 times more potent than morphine.

  • Hidden everywhere. Fentanyl is mixed into heroin, pressed into counterfeit pills made to look like real prescriptions, and cut with other dangerous adulterants.
  • Often invisible. Most people who think they are buying heroin or a pharmacy pill are actually taking fentanyl, without knowing it.
  • Fast and tiny. The dose that kills is small, and overdose can happen within minutes.

Fentanyl has reshaped treatment itself. In one survey, 89% of addiction specialists said high-potency synthetic opioids had shifted their approach, and 86% changed how they prescribe medication because of it[6].

How Big the Epidemic Actually Is

The numbers are large enough to feel abstract, so it helps to hold the human reality alongside them.

In 2024, opioid use disorder and overdose caused 53,774 deaths in the United States, a figure that has roughly doubled over the past twenty years[2]. Behind each number is a parent, a child, a coworker, a friend.

In 2022, an estimated 9.37 million US adults, about 3.7% of the adult population, met the criteria for an opioid use disorder[2].

The scale of the crisis Figure
US opioid overdose deaths, 2024 53,774
US adults with opioid use disorder, 2022 9.37 million (3.7%)
Potency of illicit fentanyl vs. morphine 50 to 100 times
People with OUD who have a second substance use disorder 59.5%
People with OUD receiving methadone or buprenorphine 25.1%

The Condition Rarely Travels Alone

Opioid use disorder almost never shows up by itself. Knowing what tends to come with it helps families understand what they are really facing.

  • Another substance, most of the time. 59.5% also have a second substance use disorder, most often involving cocaine, alcohol, or cannabis[7].
  • Depression in about a third. Roughly 36% live with depression, and many also carry anxiety or PTSD[8].
  • Early-life trauma raises the risk. Adverse childhood experiences show a dose-response link with opioid use, with more trauma tied to higher risk[9].
Did you know?

The most dangerous moment in the whole crisis is not the first use — it is the return to use after a break. After leaving jail, finishing a program, or completing detox, tolerance drops fast, and a former dose can be fatal. Surviving one overdose is a warning, not an all-clear: people who start medication after a nonfatal overdose have a markedly lower risk of a repeat[10].

Who the Epidemic Hits

This crisis is not confined to one kind of person, one income bracket, or one corner of the map. That is part of what makes it so hard for families to see coming.

It Crosses Age, Income, and Geography

  • Ordinary patients first. People prescribed pills for back pain, surgery, dental work, or injury who never expected dependence.
  • Working-age adults carry much of the toll. Overdose has become a leading cause of death for Americans in the prime of life.
  • Staggering financial damage. Overdose deaths cost the US economy hundreds of billions of dollars in lost lives and productivity in recent years[11].

The Supply, Not the Person, Drives Today’s Deaths

What changed most is not who uses, but what is in the drugs. Fentanyl now dominates the deaths, appearing in the supply far more than heroin or prescription pills[12].

  • It reaches people who never chose it. Fentanyl is hidden in counterfeit pills and other street drugs, so people who never sought it are dying from it.
  • It reaches casual users. The risk is not limited to people with long histories of addiction; first-time and occasional users are exposed too.
  • The lesson is vigilance, not blame. Anyone using street drugs today should assume fentanyl is present and keep naloxone close.

Why Overdose Is the Event that Kills

Almost every opioid death runs through one event: an overdose that stops a person’s breathing. The encouraging flip side is that this is the single most preventable moment in the whole crisis.

The Highest-Risk Moments Are Predictable

Overdose risk is not random. It spikes at specific, knowable moments — which means families and people who use can prepare for them.

Higher-risk moment Why the danger jumps
Returning to use after a break Tolerance drops fast after jail, detox, or a program, so a former dose can be fatal
Using alone No one is there to call 911 or give naloxone
Mixing with alcohol or benzodiazepines Two breathing-suppressants stacked together
An unknown street supply Fentanyl and xylazine are hidden in pills and powder[12]

Naloxone Turns a Death into a Survivable Scare

The reason overdose is so survivable is that a reversal drug exists and works fast.

  • It restores breathing within minutes. Naloxone (Narcan) is sold over the counter, so anyone can carry it.
  • Fentanyl changed the dosing math. Because fentanyl binds tightly, one dose may not be enough, and a second is often needed[13].
  • Surviving is a turning point, not a verdict. People who start medication right after are far less likely to overdose again[10].

Where the Epidemic Stands Now

Today the crisis is defined less by prescription pills than by the unpredictable street supply.

Prescribing has fallen from its peak, but the fentanyl that replaced the pills is far more lethal — which is why deaths climbed even as prescriptions dropped.

The Street Supply Keeps Getting More Dangerous

The supply now changes faster than anyone can track, and the newest threats do not respond to the usual tools.

  • Xylazine is spreading. This veterinary sedative is increasingly cut into fentanyl, especially in some East Coast cities. It does not respond to naloxone and causes severe skin wounds[14].
  • Fentanyl withdrawal is harder. It can hit harder and differently than the heroin-era withdrawal treatment was built around[15].
  • It is a moving target. The response has shifted from controlling pills to keeping people alive long enough to reach treatment.

There Is Genuine Reason for Hope

After years of relentless increases, overdose deaths have begun to level off and decline in many parts of the country.

  • Why the curve is bending. The shift is widely credited to the wider reach of naloxone, expanded access to medication, and harm-reduction efforts taking hold.
  • Not over yet. The crisis continues, and the supply keeps getting more dangerous.
  • But moving the right way. For the first time in a long time, the trend is heading in the right direction.

The Solutions that Actually Work

This is the part of the story that gets the least attention and matters the most. The epidemic is treatable, and the interventions that turn it around are not theoretical.

Did you know?

Starting medication cuts the risk of dying roughly in half, yet three out of four people with opioid use disorder are not on it. In 2022 only 25.1% received methadone or buprenorphine, even though treatment is tied to about a 50% reduction in deaths[2]. The single biggest opportunity to save lives is not a new drug — it is closing the gap to the ones that already work.

Medication for Opioid Use Disorder Is the Foundation

Medication for opioid use disorderOften called MAT, this is treatment that uses a prescribed, regulated medicine to steady the brain so cravings and withdrawal ease — letting a person stabilize rather than simply trading one habit for another.

Methadone and buprenorphine are not a lateral move from one drug to another. They quiet withdrawal and craving so a person can rebuild a life, and they save lives directly.

  • Roughly half the risk of death. Compared with no medication, treatment cuts mortality by about 50%[2][16].
  • Time in treatment compounds the benefit. Each additional month on buprenorphine is linked to a 25% drop in the odds of using non-prescribed opioids[17].
  • Detox alone is not enough. Without medication to follow, detox does not lower overdose risk the way staying in treatment does[18].

A third medication, naltrexone, blocks opioids entirely and suits people who have already gotten through withdrawal. The way out is not white-knuckling; it is getting onto the right medication and staying there.

Naloxone Is the Tool that Buys Time

Sold over the counter as Narcan, naloxone reverses an opioid overdose within minutes and cannot be misused to get high.

  • Community distribution saves lives. Programs that give it to people who use drugs and those around them measurably reduce overdose deaths[19].
  • Bystanders reverse overdoses too. Ordinary people, not just paramedics, do it every day[20].
  • One dose may not be enough. In the fentanyl era, give another while you wait for help and keep higher-dose formulations in mind[13].

Harm Reduction Keeps People Alive Until They Are Ready

Fentanyl test strips, syringe programs, and naloxone distribution are not in tension with recovery — they are upstream of it.

  • They reduce harm, not raise it. These programs cut infections and overdose deaths rather than encouraging use.
  • They open the door to care. They connect people to treatment instead of pushing them away.
  • The window after an overdose matters most. Starting medication quickly after an emergency-room visit for overdose sharply lowers the odds of another[21].

Recovery Is Real, and Here Is Where to Start

The epidemic is a story of loss, but it is also a story of hundreds of thousands of people who got their lives back, and the data backs that up.

An 18-month study of nearly 2,000 patients in treatment found that staying in care was tied to abstinence rising from 55% to 77%, alongside fewer overdoses, fewer emergency visits, and fewer arrests[22].

Recovery is usually a long-term process rather than a single event, more like managing diabetes or high blood pressure than flipping a switch. But it works, and it is available now.

If this crisis has reached you or someone you love, the next step is not to quit alone and hope. It is to get connected to medical detox and medication — the safe path, far easier than the agony people fear, leading to a life better than the one addiction allows.

The next step doesn’t have to be a big one. Our treatment centers directory can point you to the right level of care. Reaching out today is a real step forward — and one you can make right now.

Frequently asked questions

What is the opioid epidemic?

The opioid epidemic is the decades-long surge in opioid addiction and overdose death in the United States. It moved through three waves: prescription painkillers in the late 1990s, then heroin as pills got harder to get, then illicitly manufactured fentanyl, which now dominates the street supply and drives most overdose deaths. In 2024, opioid use disorder and overdose caused 53,774 deaths, roughly double the toll of twenty years earlier[2].

What are the three waves of the opioid epidemic?

The first wave began in the late 1990s with a sharp rise in prescription painkillers like OxyContin. The second wave followed as people dependent on pills moved to cheaper heroin. The third and deadliest wave is illicit fentanyl, a synthetic opioid roughly 50 to 100 times more potent than morphine that is now mixed into heroin and pressed into counterfeit pills, often without the user knowing.

How many people have died in the opioid epidemic?

In 2024 alone, opioid use disorder and opioid overdose caused 53,774 deaths in the United States, a number that has roughly doubled over the past twenty years[2]. Overdose is the event that kills, and it can be reversed with naloxone (Narcan) if someone acts fast. The risk is highest after a break in use, such as leaving jail or finishing detox, when tolerance has dropped.

Why did prescription painkillers lead to heroin and fentanyl?

After 1996, prescribing of painkillers expanded sharply, driven partly by industry research that misrepresented the addiction risk. A minority of patients became dependent, and roughly 8 to 12% of people who misuse opioids develop an opioid use disorder[3]. When pills became harder and costlier to get, many moved to cheaper street heroin, and that supply is now dominated by far more potent illicit fentanyl.

Is the opioid epidemic getting better?

After years of relentless increases, overdose deaths have begun to level off and decline in many parts of the country, a shift widely attributed to wider naloxone access, expanded medication treatment, and harm reduction taking hold. The crisis is not over, and the street supply keeps getting more dangerous, but for the first time in a long time the curve is bending in the right direction.

What solutions actually work against the opioid epidemic?

Three work together. Medication for opioid use disorder (methadone and buprenorphine) is associated with roughly half the risk of death and is the foundation of recovery[2][16]. Naloxone (Narcan) reverses overdose and saves lives in the hands of ordinary bystanders[19]. Harm reduction, such as fentanyl test strips and syringe programs, keeps people alive long enough to reach treatment. The biggest gap is access, not effectiveness: in 2022 only 25.1% of people with the disorder received medication[2].

Get Treatment Help

If you or someone you love is struggling with addiction, getting help is just a phone call away, or consider trying therapy online with BetterHelp.

Exclusive offer: 20% Off BetterHelp*

Following links to the BetterHelp website may earn us a commission that helps us manage and maintain AddictionHelp.com. *Get 20% off your first month of BetterHelp. Offer valid for new BetterHelp users only. Offer cannot be combined with insurance.

22 Sources
  1. Abdelal, Randa, Banerjee, A Raja, Carlberg-Racich, Suzanne, Darwaza, Neyla, Ito, Diane, Epstein, Josh (2022). The need for multiple naloxone administrations for opioid overdose reversals: A review of the literature. Substance abuse. https://doi.org/10.1080/08897077.2021.2010252
  2. Harris, Miriam T H, Weinstein, Zoe M, Walley, Alexander Y (2026). Medications for Opioid Use Disorder, Opioid Withdrawal, and Opioid Overdose: A Review. JAMA. https://doi.org/10.1001/jama.2025.26348
  3. Courchesne-Krak, Natasia S, Chandrasekaran, Anirudh R, Gonzalez, Jean, Bianchi, Sevim B, Tran, Vinh, Johnson, Eric O, Troiani, Vanessa, Hettema, John M, Stein, Murray B, Coon, Hilary, Docherty, Anna R, Berretini, Wade H, MacKillop, James, de Wit, Harriet, Marienfeld, Carla, Palmer, Abraham A, Sanchez-Roige, Sandra (2025). Prescription Opioid Medication Survey: A Tool to Collect Deep Phenotypic Data on the Multifactorial Pathways to Opioid Use Disorder in Clinical and Population-Based Cohorts. Complex psychiatry. https://doi.org/10.1159/000546389
  4. Cicero, Theodore J, Ellis, Matthew S (2015). Abuse-Deterrent Formulations and the Prescription Opioid Abuse Epidemic in the United States: Lessons Learned From OxyContin. JAMA psychiatry. https://doi.org/10.1001/jamapsychiatry.2014.3043
  5. Coplan, Paul M, Kale, Hrishikesh, Sandstrom, Lauren, Landau, Craig, Chilcoat, Howard D (2013). Changes in oxycodone and heroin exposures in the National Poison Data System after introduction of extended-release oxycodone with abuse-deterrent characteristics. Pharmacoepidemiology and drug safety. https://doi.org/10.1002/pds.3522
  6. Weleff, Jeremy, Christian, Nicholaus J, Wang, James X, Singh, Mohit, De Aquino, Joao P, Saxon, Andrew J, Vassallo, Gabriela Garcia (2025). Navigating new norms: Addiction specialists' perspectives on opioid use disorder treatments and policy challenges in the fentanyl era. The American journal on addictions. https://doi.org/10.1111/ajad.13653
  7. Santo, Thomas, Gisev, Natasa, Campbell, Gabrielle, Colledge-Frisby, Samantha, Wilson, Jack, Tran, Lucy Thi, Lynch, Michelle, Martino-Burke, Daniel, Taylor, Sophia, Degenhardt, Louisa (2024). Prevalence of comorbid substance use disorders among people with opioid use disorder: A systematic review & meta-analysis. The International journal on drug policy. https://doi.org/10.1016/j.drugpo.2024.104434
  8. Santo, Thomas, Campbell, Gabrielle, Gisev, Natasa, Martino-Burke, Daniel, Wilson, Jack, Colledge-Frisby, Samantha, Clark, Brodie, Tran, Lucy Thi, Degenhardt, Louisa (2022). Prevalence of mental disorders among people with opioid use disorder: A systematic review and meta-analysis. Drug and alcohol dependence. https://doi.org/10.1016/j.drugalcdep.2022.109551
  9. Regmi, Sanjaya, Kedia, Satish K, Ahuja, Nikhil A, Lee, Guijin, Entwistle, Coree, Dillon, Patrick J (2024). Association Between Adverse Childhood Experiences and Opioid Use-Related Behaviors: A Systematic Review. Trauma, violence & abuse. https://doi.org/10.1177/15248380231205821
  10. Crystal, Stephen, Nowels, Molly, Samples, Hillary, Olfson, Mark, Williams, Arthur Robin, Treitler, Peter (2022). Opioid overdose survivors: Medications for opioid use disorder and risk of repeat overdose in Medicaid patients. Drug and alcohol dependence. https://doi.org/10.1016/j.drugalcdep.2022.109269
  11. Mahadeo, Shalinie, Lui, Briana, Khusid, Elizabeth, Weber, Marissa, Jotwani, Rohan, Hoyler, Marguerite, White, Robert S (2024). Economic losses resulting from opioid overdose deaths in the United States between 2018 and 2020: By opioid type. Journal of opioid management. https://doi.org/10.5055/jom.0871
  12. Garnett, Matthew F, Cisewski, Jodi A, Ahmad, Farida B (2026). Drugs Most Frequently Involved in Drug Overdose Deaths: United States, 2017-2023. National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System. https://doi.org/10.15620/cdc/174640
  13. Carpenter, Joseph, Murray, Brian Patrick, Atti, Sukhshant, Moran, Tim P, Yancey, Arthur, Morgan, Brent (2020). Naloxone Dosing After Opioid Overdose in the Era of Illicitly Manufactured Fentanyl. Journal of medical toxicology : official journal of the American College of Medical Toxicology. https://doi.org/10.1007/s13181-019-00735-w
  14. Khatri, Shailesh N, Sadek, Safiyah, Kendrick, Percell T, Bondy, Emma O, Hong, Mei, Pauss, Sally, Luo, Dan, Prisinzano, Thomas E, Dunn, Kelly E, Marusich, Julie A, Beckmann, Joshua S, Hinds, Terry D, Gipson, Cassandra D (2024). Xylazine suppresses fentanyl consumption during self-administration and induces a unique sex-specific withdrawal syndrome that is not altered by naloxone in rats. Experimental and clinical psychopharmacology. https://doi.org/10.1037/pha0000670
  15. Sharma, Anjalee, Dunn, Kelly E, Schmid-Doyle, Katja, Dowell, Sarah, Kim, Narie, Strain, Eric C, Bergeria, Cecilia (2025). Examining the Severity and Progression of Illicitly Manufactured Fentanyl Withdrawal: A Quasi-experimental Comparison. Journal of addiction medicine. https://doi.org/10.1097/adm.0000000000001395
  16. Perry, Danielle, Kirkwood, Jessica Em, Doroshuk, Marissa L, Kelmer, Michael, Korownyk, Christina S, Ton, Joey, Garrison, Scott R (2025). Opioid agonist therapy for opioid use disorder in primary versus specialty care. The Cochrane database of systematic reviews. https://doi.org/10.1002/14651858.cd013672.pub2
  17. Jiang, Xinyi, Guy, Gery P, Dever, Jill A, Richardson, John S, Dunlap, Laura J, Turcios, Didier, Wolicki, Sara Beth, Edlund, Mark J, Losby, Jan L (2025). Association Between Length of Buprenorphine or Methadone Use and Nonprescribed Opioid Use Among Individuals with Opioid Use Disorder: A Cohort Study. Substance use & addiction journal. https://doi.org/10.1177/29767342241266038
  18. Wakeman, Sarah E, Larochelle, Marc R, Ameli, Omid, Chaisson, Christine E, McPheeters, Jeffrey Thomas, Crown, William H, Azocar, Francisca, Sanghavi, Darshak M (2020). Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder. JAMA network open. https://doi.org/10.1001/jamanetworkopen.2019.20622
  19. Fischer, Leah S, Asher, Alice, Stein, Renee, Becasen, Jeffrey, Doreson, Amanda, Mermin, Jonathan, Meltzer, Martin I, Edlin, Brian R (2025). Effectiveness of naloxone distribution in community settings to reduce opioid overdose deaths among people who use drugs: a systematic review and meta-analysis. BMC public health. https://doi.org/10.1186/s12889-025-22210-8
  20. Schwartz, David G, Ataiants, Janna, Roth, Alexis, Marcu, Gabriela, Yahav, Inbal, Cocchiaro, Benjamin, Khalemsky, Michael, Lankenau, Stephen (2020). Layperson reversal of opioid overdose supported by smartphone alert: A prospective observational cohort study. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2020.100474
  21. Samples, Hillary, Cook, Sharon, Hua, Jialiang, Treitler, Peter, Stone, Elizabeth M, Miles, Jennifer, Olfson, Mark, Crystal, Stephen (2026). Timely Receipt of New Medication Treatment After Acute Care Encounters for Opioid Overdose in the U.S. Medicaid Population. Journal of general internal medicine. https://doi.org/10.1007/s11606-025-10108-5
  22. Dever, Jill A, Hertz, Marci F, Dunlap, Laura J, Richardson, John S, Wolicki, Sara Beth, Biggers, Bradley B, Edlund, Mark J, Bohm, Michele K, Turcios, Didier, Jiang, Xinyi, Zhou, Hong, Evans, Mary E, Guy, Gery P (2024). The Medications for Opioid Use Disorder Study: Methods and Initial Outcomes From an 18-Month Study of Patients in Treatment for Opioid Use Disorder. Public health reports (Washington, D.C. : 1974). https://doi.org/10.1177/00333549231222479
Written by
Jessica Miller is the Content Manager of Addiction Help

Editorial Director

Jessica Miller is the Editorial Director of Addiction Help. Jessica graduated from the University of South Florida (USF) with an English degree and combines her writing expertise and passion for helping others to deliver reliable information to those impacted by addiction. Informed by her personal journey to recovery and support of loved ones in sobriety, Jessica's empathetic and authentic approach resonates deeply with the Addiction Help community.

Reviewed by
  • Fact-Checked
  • Editor
Kent S. Hoffman, D.O. is a founder of Addiction Help

Co-Founder & Chief Medical Officer

Kent S. Hoffman, D.O. has been an expert in addiction medicine for more than 15 years. In addition to managing a successful family medical practice, Dr. Hoffman is board certified in addiction medicine by the American Osteopathic Academy of Addiction Medicine (AOAAM). Dr. Hoffman has successfully treated hundreds of patients battling addiction. Dr. Hoffman is the Co-Founder and Chief Medical Officer of AddictionHelp.com and ensures the website’s medical content and messaging quality.

Real Help. Real Recovery.

Compare centers, explore options and start your path to recovery today.

Find Treatment Now

"AddictionHelp.com is helping to make recovery available to EVERYONE!"

- Angela N.